Insider Trades37 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2026 | Sell | ASTH | Brandon Sim | CEO and President | 1,093 | $44.51 | $2.2B | -12.91% | +148.56% | $48.6K | -0.09% | — | Stalk |
| May 16, 2026 | Sell | ASTH | Chandan Basho | COO and CFO | 8,155 | $38.26 | $2.2B | -12.91% | +148.56% | $312.0K | -4.86% | — | Stalk |
| Apr 14, 2026 | Sell | ASTH | Chandan Basho | COO and CFO | 3,870 | $29.07 | $2.2B | -12.91% | +148.56% | $112.5K | -2.25% | — | Stalk |
| Apr 2, 2026 | Sell | ASTH | Chandan Basho | COO and CFO | 2,092 | $25.05 | $2.2B | -12.91% | +148.56% | $52.4K | -1.20% | — | Stalk |
| Apr 1, 2026 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 57,980 | $24.51 | $2.2B | -12.91% | +148.56% | $1.4M | -24.61% | — | Stalk |
| Mar 26, 2026 | Sell | ASTH | Glenn Sobotka | Chief Accounting Officer | 662 | $24.27 | $2.2B | -12.91% | +148.56% | $16.1K | -4.50% | — | Stalk |
| Mar 5, 2026 | Sell | ASTH | Chandan Basho | COO and CFO | 1,240 | $25.07 | $2.2B | -12.91% | +148.56% | $31.1K | -0.71% | — | Stalk |
| Mar 5, 2026 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 1,697 | $25.07 | $2.2B | -12.91% | +148.56% | $42.5K | -0.84% | — | Stalk |
| Feb 2, 2026 | Buy | ASTH | Brandon Sim | CEO and President | 21,334 | $23.24 | $2.2B | -12.91% | +148.56% | $495.8K | +2.08% | — | Stalk |
| Jan 23, 2026 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 10,759 | $27.16 | $2.2B | -12.91% | +148.56% | $292.2K | -5.06% | — | Stalk |
| Jan 1, 2026 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 5,102 | $24.81 | $2.2B | -12.91% | +148.56% | $126.6K | -2.34% | — | Stalk |
| Nov 10, 2025 | Buy | ASTH | Kenneth T. Sim | Executive Chairman | 29,502 | $17.78 | $2.2B | -12.91% | +148.56% | $524.5K | +4.84% | — | Stalk |
| Oct 2, 2025 | Sell | ASTH | Chandan Basho | COO and CFO | 1,979 | $27.77 | $2.2B | -12.91% | +148.56% | $55.0K | -1.12% | — | Stalk |
| Sep 5, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 1,694 | $29.70 | $2.2B | -12.91% | +148.56% | $50.3K | -0.77% | — | Stalk |
| Sep 5, 2025 | Sell | ASTH | Chandan Basho | COO and CFO | 1,694 | $29.70 | $2.2B | -12.91% | +148.56% | $50.3K | -0.95% | — | Stalk |
| Jul 1, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 6,831 | $25.06 | $2.2B | -12.91% | +148.56% | $171.2K | -3.03% | — | Stalk |
| Jun 4, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 1,656 | $25.06 | $2.2B | -12.91% | +148.56% | $41.5K | -0.73% | — | Stalk |
| May 16, 2025 | Sell | ASTH | Chandan Basho | COO and CFO | 10,035 | $27.18 | $2.2B | -12.91% | +148.56% | $272.8K | -5.32% | — | Stalk |
| Apr 29, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 828 | $31.15 | $2.2B | -12.91% | +148.56% | $25.8K | -0.36% | — | Stalk |
| Apr 14, 2025 | Sell | ASTH | Chandan Basho | COO and CFO | 2,683 | $34.05 | $2.2B | -12.91% | +148.56% | $91.4K | -1.40% | — | Stalk |
| Apr 2, 2025 | Sell | ASTH | Chandan Basho | COO and CFO | 1,394 | $30.02 | $2.2B | -12.91% | +148.56% | $41.8K | -0.72% | — | Stalk |
| Mar 5, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 7,866 | $27.19 | $2.2B | -12.91% | +148.56% | $213.9K | -3.33% | — | Stalk |
| Mar 5, 2025 | Sell | ASTH | Brandon Sim | CEO and President | 105,795 | $27.19 | $2.2B | -12.91% | +148.56% | $2.9M | -9.37% | — | Stalk |
| Jan 23, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 7,210 | $37.96 | $2.2B | -12.91% | +148.56% | $273.7K | -3.33% | — | Stalk |
| Jan 1, 2025 | Sell | ASTH | Dinesh M. Kumar | Chief Medical Officer | 967 | $31.53 | $2.2B | -12.91% | +148.56% | $30.5K | -0.45% | — | Stalk |
| Nov 30, 2024 | Sell | ASTH | John Vong | Chief Accounting Officer | 134 | $43.25 | $2.2B | -12.91% | +148.56% | $5.8K | -0.76% | — | Stalk |
| Nov 18, 2024 | Buy | ASTH | Kenneth T. Sim | Executive Chairman | 28,046 | $18.65 | $2.2B | -12.91% | +148.56% | $523.1K | +4.82% | — | Stalk |
| Nov 12, 2024 | Sell | ASTH | John Vong | Chief Accounting Officer | 636 | $42.91 | $2.2B | -12.91% | +148.56% | $27.3K | -3.48% | — | Stalk |
| Nov 8, 2024 | Sell | ASTH | Chandan Basho | COO and CFO | 691 | $46.96 | $2.2B | -12.91% | +148.56% | $32.4K | -0.41% | — | Stalk |
| Oct 2, 2024 | Sell | ASTH | Brandon Sim | CEO and President | 2,626 | $57.87 | $2.2B | -12.91% | +148.56% | $152.0K | -0.28% | — | Stalk |
| Aug 1, 2024 | Sell | ASTH | John Vong | Chief Accounting Officer | 67 | $51.57 | $2.2B | -12.91% | +148.56% | $3.5K | -0.36% | — | Stalk |
| Aug 1, 2024 | Sell | ASTH | Dinesh M. Kumar | — | 794 | $51.57 | $2.2B | -12.91% | +148.56% | $40.9K | -0.53% | — | Stalk |
| Jul 11, 2024 | Sell | ASTH | John Vong | Chief Accounting Officer | 336 | $45.00 | $2.2B | -12.91% | +148.56% | $15.1K | -1.80% | — | Stalk |
| May 16, 2024 | Sell | ASTH | Chandan Basho | COO and CFO | 7,051 | $41.13 | $2.2B | -12.91% | +148.56% | $290.0K | -4.45% | — | Stalk |
| May 12, 2024 | Sell | ASTH | John Vong | Chief Accounting Officer | 636 | $38.89 | $2.2B | -12.91% | +148.56% | $24.7K | -3.30% | — | Stalk |
| Mar 29, 2024 | Sell | ASTH | Chandan Basho | COO and CFO | 14,500 | $41.29 | $2.2B | -12.91% | +148.56% | $598.7K | -4.28% | — | Stalk |
| Mar 29, 2024 | Sell | ASTH | Brandon Sim | CEO and President | 37,957 | $41.99 | $2.2B | -12.91% | +148.56% | $1.6M | -3.84% | — | Stalk |